IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention—Results from Randomized Controlled Trials
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126400 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nina M T Meyer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism (Diabetes and Nutritional Medicine), Charité Universitätsmedizin Berlin, 10117 Berlin, Germany. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 1, Insulin-Like Growth Factor I, Life Style, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Diabetes Stiftung, German Center for Diabetes Research, California Walnut Commission, Folsom, CA, USA.
Abstract (Originalsprache)
Lifestyle interventions can prevent type 2 diabetes (T2DM). However, some individuals do not experience anticipated improvements despite weight loss. Biomarkers to identify such individuals at early stages are lacking. Insulin-like growth factor 1 (IGF- 1) and Insulin-like growth factor binding protein 1(IGFBP-1) were shown to predict T2DM onset in prediabetes. We assessed whether these markers also predict the success of lifestyle interventions, thereby possibly guiding personalized strategies. We analyzed the fasting serum levels of IGF-1, IGFBP-1, and Insulin-like growth factor binding protein 2 (IGFBP-2) in relation to changes in metabolic and anthropometric parameters, including intrahepatic lipids (IHLs) and visceral adipose tissue (VAT) volume, measured by magnetic resonance imaging (MRI), in 345 participants with a high risk for prediabetes (54% female; aged 36–80 years). Participants were enrolled in three randomized dietary intervention trials and assessed both at baseline and one year post-intervention. Statistical analyses were performed using IBM SPSS Statistics (version 28), and significance was set at p < 0.05. Within the 1-year intervention, overall significant improvements were observed. Stratifying individuals by baseline IGF-1 and IGFBP-1 percentiles revealed significant differences: higher IGF-1 levels were associated with more favorable changes compared to lower levels, especially in VAT and IHL. Lower baseline IGFBP-1 levels were associated with greater improvements, especially in IHL and 2 h glucose. Higher bioactive IGF-1 levels might predict better metabolic outcomes following lifestyle interventions in prediabetes, potentially serving as biomarkers for personalized interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism (Diabetes and Nutritional Medicine), Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.
- German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.
- Department of Clinical Nutrition/DZD, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany.
- Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich, Eberhard Karls University of Tübingen, 72076 Tübingen, Germany.
- Department of Internal Medicine IV-Endocrinology, Diabetology, and Nephrology, University Hospital Tübingen, 72076 Tübingen, Germany.
- Department of Diabetes, School of Life Course Science and Medicine, King's College London, London WC2R 2LS, UK.
ORCID-Profile: Stefan Kabisch, Peter E H Schwarz, Jürgen Machann, Martin O Weickert
Förderung
- Deutsche Diabetes Stiftung
- German Center for Diabetes Research
- California Walnut Commission, Folsom, CA, USA
- J. Rettenmaier & Soehne GmbH + Co KG, Holzmuehle, Germany
- German Center for Diabetes Research (DZD) in Neuherberg, Germany
- California Walnut Commission in Folsom, CA, USA
- German Diabetes Foundation (Deutsche Diabetes Stiftung, DDS) in Düsseldorf, Germany
- J. Rettenmaier & Soehne GmbH + Co KG in Holzmuehle, Germany
Zitieren
APA
Meyer, N. M. T., Kabisch, S., Dambeck, U., Honsek, C., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Schwarz, P. E. H., Machann, J., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H. (2024). IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention—Results from Randomized Controlled Trials. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126400
Vancouver
Meyer NMT, Kabisch S, Dambeck U, Honsek C, Kemper M, Gerbracht C, et al. IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention—Results from Randomized Controlled Trials. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126400
BibTeX
@article{Meyer2024,
author = {Meyer, Nina M T and Kabisch, Stefan and Dambeck, Ulrike and Honsek, Caroline and Kemper, Margrit and Gerbracht, Christiana and Arafat, Ayman M and Birkenfeld, Andreas L and Schwarz, Peter E H and Machann, Jürgen and Osterhoff, Martin A and Weickert, Martin O and Pfeiffer, Andreas F H},
title = {IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention—Results from Randomized Controlled Trials},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126400}
}
EUVIMED